This leaflet answers some common questions about Ryzodeg ® 70/30 FlexTouch ®. It does not contain all the available information. It does not take the place of talking to your doctor, diabetes ...
This leaflet answers some common questions about Ryzodeg ® 70/30 Penfill ®. It does not contain all the available information. It does not take the place of talking to your doctor, diabetes ...
The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes treatments Tresiba and Ryzodeg. The approval covers all 27 European Union member states. Tresiba ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback